RLYB vs. CLNN
RLYB (Rallybio Corporation) and CLNN (Clene Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, RLYB returned -36.91%/yr vs -34.82%/yr for CLNN. At a 0.12 correlation, their price movements are largely independent.
Performance
RLYB vs. CLNN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RLYB achieves a 192.78% return, which is significantly higher than CLNN's -1.87% return.
RLYB
- 1D
- -0.99%
- 1M
- 13.81%
- YTD
- 192.78%
- 6M
- 204.36%
- 1Y
- 583.02%
- 3Y*
- -36.91%
- 5Y*
- —
- 10Y*
- —
CLNN
- 1D
- -1.87%
- 1M
- -28.80%
- YTD
- -1.87%
- 6M
- -20.22%
- 1Y
- 46.94%
- 3Y*
- -34.82%
- 5Y*
- -51.34%
- 10Y*
- —
RLYB vs. CLNN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
RLYB Rallybio Corporation | 192.78% | -28.53% | -59.83% | -63.62% | -31.13% | -32.34% |
CLNN Clene Inc. | -1.87% | 10.55% | -10.49% | -70.34% | -75.61% | -49.32% |
Correlation
The correlation between RLYB and CLNN is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021 | 0.12 |
Fundamentals
RLYB:
$91.42M
CLNN:
$67.07M
RLYB:
-$1.41
CLNN:
-$3.24
RLYB:
103.99
CLNN:
443.94
RLYB:
$858.00K
CLNN:
$134.00K
RLYB:
$643.00K
CLNN:
$96.00K
RLYB:
-$32.06M
CLNN:
-$23.91M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RLYB vs. CLNN — Risk / Return Rank
RLYB
CLNN
RLYB vs. CLNN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rallybio Corporation (RLYB) and Clene Inc. (CLNN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RLYB | CLNN | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 5.04 | 0.43 | +4.61 |
Sortino ratioReturn per unit of downside risk | 5.33 | 1.43 | +3.90 |
Omega ratioGain probability vs. loss probability | 1.62 | 1.18 | +0.44 |
Calmar ratioReturn relative to maximum drawdown | 18.95 | 0.69 | +18.26 |
Martin ratioReturn relative to average drawdown | 44.22 | 1.18 | +43.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RLYB | CLNN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 5.04 | 0.43 | +4.61 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.50 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.30 | -0.42 | +0.11 |
Drawdowns
RLYB vs. CLNN - Drawdown Comparison
The maximum RLYB drawdown since its inception was -98.93%, roughly equal to the maximum CLNN drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for RLYB and CLNN.
Loading charts...
Drawdown Indicators
| RLYB | CLNN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.93% | -99.27% | +0.34% |
Max Drawdown (1Y)Largest decline over 1 year | -31.05% | -68.64% | +37.59% |
Max Drawdown (3Y)Largest decline over 3 years | -97.19% | -89.13% | -8.06% |
Max Drawdown (5Y)Largest decline over 5 years | — | -99.13% | — |
Current DrawdownCurrent decline from peak | -91.42% | -98.23% | +6.81% |
Average DrawdownAverage peak-to-trough decline | -79.17% | -84.68% | +5.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.28% | 39.77% | -26.49% |
Volatility
RLYB vs. CLNN - Volatility Comparison
The current volatility for Rallybio Corporation (RLYB) is 19.93%, while Clene Inc. (CLNN) has a volatility of 30.10%. This indicates that RLYB experiences smaller price fluctuations and is considered to be less risky than CLNN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RLYB | CLNN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.93% | 30.10% | -10.17% |
Volatility (6M)Calculated over the trailing 6-month period | 72.03% | 75.50% | -3.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 116.79% | 111.80% | +4.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 109.57% | 103.31% | +6.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 109.57% | 112.76% | -3.19% |
Dividends
RLYB vs. CLNN - Dividend Comparison
Neither RLYB nor CLNN has paid dividends to shareholders.
Financials
RLYB vs. CLNN - Financials Comparison
This section allows you to compare key financial metrics between Rallybio Corporation and Clene Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RLYB and CLNN have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CLNN has higher volatility (30.10%) compared to RLYB (19.93%). In terms of maximum drawdown, RLYB dropped -98.93% vs CLNN's -99.27%.
RLYB currently has the higher Sharpe Ratio (5.04 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RLYB and CLNN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer